Axioma Group, Inc.

BioPharma Future

Strategy + Innovation Insights

If you are seeking to learn more about the strategy and innovation within the biopharmaceutical industry or the work done by Axioma Strategy, look no further. This page will comprise a collection of brief "strategy bites" that are both newsworthy and informative, designed to be thought-provoking and spark new ideas.

strategic initatives
12 May, 2023
Driving Growth and Innovation: The Power of Strategic Initiatives
one cube stands out
09 May, 2023
Preparing BioPharma executives to embrace AI-driven innovation
international person
18 Apr, 2023
Launching Your Product Abroad: Key Considerations for International Business Development in BioPharma
strategic leap
11 Apr, 2023
How to Plan, Implement, and Succeed with Long-term Programs that Align with Your Organization's Vision
Music Industry Logos
01 Apr, 2023
The biopharmaceuticals industry can learn from the mistakes made by the music industry when faced with disruption. The music industry's early attempts to stifle digital consumption by taking action against file-sharing services were unnecessary and counterproductive, said the article, and the music industry would have benefitted from looking at what its customers really wanted. Similarly, pharmaceutical companies risk ignoring patients' needs in favour of maintaining the status quo. A greater focus on technology-enabled convenience and value, as well as partnerships with startups, among other things, could help the pharmaceutical industry to stay competitive.
Share by: